154 related articles for article (PubMed ID: 3948152)
1. Characterization of the individual transport routes that mediate the influx and efflux of methotrexate in CCRF-CEM human lymphoblastic cells.
Henderson GB; Tsuji JM; Kumar HP
Cancer Res; 1986 Apr; 46(4 Pt 1):1633-8. PubMed ID: 3948152
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the multiple transport routes for methotrexate in L1210 cells using phthalate as a model anion substrate.
Henderson GB; Zevely EM
J Membr Biol; 1985; 85(3):263-8. PubMed ID: 3897547
[TBL] [Abstract][Full Text] [Related]
3. Transport routes utilized by L1210 cells for the influx and efflux of methotrexate.
Henderson GB; Zevely EM
J Biol Chem; 1984 Feb; 259(3):1526-31. PubMed ID: 6693422
[TBL] [Abstract][Full Text] [Related]
4. The issues of transport multiplicity and energetics pertaining to methotrexate efflux in L1210 cells addressed by an analysis of cis and trans effects of inhibitors.
Sirotnak FM; O'Leary DF
Cancer Res; 1991 Mar; 51(5):1412-7. PubMed ID: 1997179
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate efflux in L1210 cells. Kinetic and specificity properties of the efflux system sensitive to bromosulfophthalein and its possible identity with a system which mediates the efflux of 3',5'-cyclic AMP.
Henderson GB; Tsuji JM
J Biol Chem; 1987 Oct; 262(28):13571-8. PubMed ID: 2820975
[TBL] [Abstract][Full Text] [Related]
6. Identification of cholate as a shared substrate for the unidirectional efflux systems for methotrexate in L1210 mouse cells.
Henderson GB; Tsuji JM
Biochim Biophys Acta; 1990 Jan; 1051(1):60-70. PubMed ID: 2297542
[TBL] [Abstract][Full Text] [Related]
7. Identification of the bromosulfophthalein-sensitive efflux route for methotrexate as the site of action of vincristine in the vincristine-dependent enhancement of methotrexate uptake in L1210 cells.
Henderson GB; Tsuji JM
Cancer Res; 1988 Nov; 48(21):5995-6001. PubMed ID: 2844396
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of probenecid on the individual transport routes which mediate the influx and efflux of methotrexate in L1210 cells.
Henderson GB; Zevely EM
Biochem Pharmacol; 1985 May; 34(10):1725-9. PubMed ID: 4004888
[TBL] [Abstract][Full Text] [Related]
9. Transport of folate compounds by leukemic cells. Evidence for a single influx carrier for methotrexate, 5-methyltetrahydrofolate, and folate in CCRF-CEM human lymphoblasts.
Henderson GB; Tsuji JM; Kumar HP
Biochem Pharmacol; 1987 Sep; 36(18):3007-14. PubMed ID: 3477231
[TBL] [Abstract][Full Text] [Related]
10. 5,10-Dideazatetrahydrofolic acid (DDATHF) transport in CCRF-CEM and MA104 cell lines.
Pizzorno G; Cashmore AR; Moroson BA; Cross AD; Smith AK; Marling-Cason M; Kamen BA; Beardsley GP
J Biol Chem; 1993 Jan; 268(2):1017-23. PubMed ID: 8419310
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of unidirectional extrusion routes for methotrexate and cholate in an efflux variant of L1210 cells.
Henderson GB; Hughes TR
Biochim Biophys Acta; 1993 Oct; 1152(1):91-8. PubMed ID: 8399310
[TBL] [Abstract][Full Text] [Related]
12. Comparison of transport properties of the reduced folate carrier and folate receptor in murine L1210 leukemia cells.
Sierra EE; Brigle KE; Spinella MJ; Goldman ID
Biochem Pharmacol; 1995 Oct; 50(8):1287-94. PubMed ID: 7488246
[TBL] [Abstract][Full Text] [Related]
13. Transport of folate compounds in L1210 cells: kinetic evidence that folate influx proceeds via the high-affinity transport system for 5-methyltetrahydrofolate and methotrexate.
Henderson GB; Suresh MR; Vitols KS; Huennekens FM
Cancer Res; 1986 Apr; 46(4 Pt 1):1639-43. PubMed ID: 3948153
[TBL] [Abstract][Full Text] [Related]
14. Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.
Spinella MJ; Brigle KE; Sierra EE; Goldman ID
J Biol Chem; 1995 Apr; 270(14):7842-9. PubMed ID: 7713875
[TBL] [Abstract][Full Text] [Related]
15. ATP-dependent efflux of 2,4-dinitrophenyl-S-glutathione. Properties of two distinct transport systems in inside-out vesicles from L1210 cells and a variant subline with altered efflux of methotrexate and cholate.
Saxena M; Henderson GB
J Biol Chem; 1995 Mar; 270(10):5312-9. PubMed ID: 7890643
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates.
Jansen G; Westerhof GR; Jarmuszewski MJ; Kathmann I; Rijksen G; Schornagel JH
J Biol Chem; 1990 Oct; 265(30):18272-7. PubMed ID: 2211701
[TBL] [Abstract][Full Text] [Related]
17. Separation and inhibitor specificity of a second unidirectional efflux route for methotrexate in L1210 cells.
Henderson GB
Biochim Biophys Acta; 1992 Oct; 1110(2):137-43. PubMed ID: 1390842
[TBL] [Abstract][Full Text] [Related]
18. A novel class of genetic variants of the L1210 cell up-regulated for folate analogue transport inward. Isolation, characterization, and degree of metabolic instability of the system.
Sirotnak FM; Moccio DM; Yang CH
J Biol Chem; 1984 Nov; 259(21):13139-44. PubMed ID: 6490649
[TBL] [Abstract][Full Text] [Related]
19. Distinct systems mediate the unidirectional efflux of methotrexate and cholate in human CCRF-CEM cells.
Henderson GB; Hughes TR; Saxena M
Arch Biochem Biophys; 1995 Jan; 316(1):77-82. PubMed ID: 7840681
[TBL] [Abstract][Full Text] [Related]
20. Carrier-mediated transport of folate compounds in L1210 cells. Initial rate kinetics and extent of duality of entry routes for folic acid and diastereomers of 5-methyltetrahydrohomofolate in the presence of physiological anions.
Sirotnak FM; Goutas LJ; Jacobsen DM; Mines LS; Barrueco JR; Gaumont Y; Kisliuk RL
Biochem Pharmacol; 1987 May; 36(10):1659-67. PubMed ID: 3593392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
